Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
606-02-010 ISMRM Abstract

³¹P-MRSI Reveals Bioenergetic Upregulation and Impaired Membrane Turnover in PD with REM Sleep Behavior Disorder

Primary: Neuro - Parkinson's Disease
Secondary: Neuro
606-02-010 · Beyond Protons: Advances in Multinuclear and Hyperpolarized MRI · Thursday, 14 May, 1:40 PM–3:30 PM · Auditorium 2
Keywords: Parkinson's Disease Phosphorous Magnetic Resonance Spectroscopy REM sleep behavior disorder
Accepted
Yan Li 1, Qiurong Yu1,2, Pei Huang1, Jinyuan Weng3, Peng Wu3, Haipeng Dong1, E. Mark Haacke1, Shengdi Chen1, Fuhua Yan1,2, Naying He1,2
1Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China
Presenting Author: Yan Li

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Iranzo A, Cochen De Cock V, Fantini ML, Pérez-Carbonell L, Trotti LM. Sleep and sleep disorders in people with Parkinson’s disease. The Lancet Neurology. 2024;23:925–937. doi: 10.1016/S1474-4422(24)00170-4. [doi]
2. Ongari G, Ghezzi C, Di Martino D, et al. Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson’s Disease? Movement Disorders. 2024;39:294–304. doi: 10.1002/mds.29643. [doi]
3. Hu Y, Yu S-Y, Zuo L-J, et al. Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD. Ferri R, editor. PLOS ONE. 2015;10:e0138997. doi: 10.1371/journal.pone.0138997. [doi]
4. Nobileau A, Gaurav R, Chougar L, et al. Neuromelanin‐Sensitive Magnetic Resonance Imaging Changes in the Locus Coeruleus/Subcoeruleus Complex in Patients with Typical and Atypical Parkinsonism. Movement Disorders. 2023;38:479–484. doi: 10.1002/mds.29309. [doi]
5. Jing Y, Haeger A, Boumezbeur F, Binkofski F, Reetz K, Romanzetti S. Neuroenergetic alterations in neurodegenerative diseases: A systematic review and meta-analysis of in vivo 31P-MRS studies. Ageing Research Reviews. 2024;101:102488. doi: 10.1016/j.arr.2024.102488. [doi]
6. Li SX, Wing YK, Lam SP, et al. Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep Medicine. 2010;11:43–48. doi: 10.1016/j.sleep.2009.06.008. [doi]
7. Mevenkamp J, Bruls YMH, Mancilla R, et al. Development of a 31P magnetic resonance spectroscopy technique to quantify NADH and NAD+ at 3 T. Nature Communications. 2024;15:9159. doi: 10.1038/s41467-024-53292-4. [doi]
8. Li Z, Agellon LB, Allen TM, et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metabolism. 2006;3:321–331. doi: 10.1016/j.cmet.2006.03.007. [doi]
9. Forester BP, Berlow YA, Harper DG, et al. Age‐related changes in brain energetics and phospholipid metabolism. NMR in Biomedicine. 2010;23:242–250. doi: 10.1002/nbm.1444. [doi]
10. Prasuhn J, Schiefen T, Güber T, et al. Levodopa Impairs the Energy Metabolism of the Basal Ganglia In Vivo. Annals of Neurology. 2024;95:849–857. doi: 10.1002/ana.26884. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/606-02-010